kabutan

Renascience Inc.(4889) Summary

4889
TSE Growth
Renascience Inc.
2,029
JPY
-7
(-0.34%)
Mar 13, 3:30 pm JST
12.72
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
2,011
Mar 13, 11:57 pm JST
Summary Chart Historical News Financial Result
PER
PBR
11.4
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,000 JPY 12.56 USD
Previous Close Mar 12
2,036 JPY 12.80 USD
High Mar 13, 10:10 am
2,069 JPY 13.00 USD
Low Mar 13, 9:06 am
1,981 JPY 12.45 USD
Volume
328,700
Trading Value
0.67B JPY 4.18M USD
VWAP
2026.56 JPY 12.71 USD
Minimum Trading Value
202,900 JPY 1,272 USD
Market Cap
0.03T JPY 0.17B USD
Number of Trades
1,412
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
3,889
1-Year High May 21, 2025
38,929
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 1,429,900
Feb 27, 2026 0 1,433,600
Feb 20, 2026 200 1,553,900 7769.50
Feb 13, 2026 0 1,564,200
Feb 6, 2026 0 1,466,100
Company Profile
Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on developing therapeutic drugs using small molecule compounds and leverages AI for medical solutions.
Sector
Pharmaceuticals
Renascience Inc., a drug discovery venture born out of Tohoku University, is advancing the development of therapeutic drugs using small molecule compounds, with a focus on PAI-1 inhibitors. The company conducts clinical development in areas related to aging and lifestyle-associated diseases, including cancer, respiratory diseases, and mental disorders, and has a strong track record in physician-led clinical trials. Renascience Inc. is also committed to developing AI-powered medical devices, with pipelines in pulmonary function test diagnostics, maintenance hemodialysis support, and diabetes treatment assistance. The company emphasizes collaborative research with universities and medical institutions, having established an open innovation laboratory. With an integrated research and development system spanning from basic research to clinical development, Renascience Inc. aims to create medical innovations.